Back to results
US 2014/0194440 A1Published application
5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
AssigneeAbbVie Deutschland GmbH & Co. KG
InventorsWilfried Braje, Thorsten Oost, Astrid Netz, Wolfgang Wernet, Liliane Unger, Wilfried Hornberger, Wilfried Lubisch
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel 5,6-disubstituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the manufacture of a medicament.
Claims6
A compound of the formula I
- in which
- R1 and R2 are independently of one another hydrogen, C1-C3-alkyl, C1-C3-fluoroalkyl, C1-C3-alkoxy, C1-C3-fluoroalkoxy, halogen or CN;
- R3 is hydrogen or C1-C4-alkyl;
- R4 is ethoxy, fluorinated ethoxy or isopropoxy;
- R5 is hydrogen or methyl;
- R6 is Br, Cl, F or CN;
- R7 is Cl, F or CN;
- R8 and R9 are independently of one another C1-C3-alkyl or C1-C3-fluoroalkyl;
- X1 is O, NH or CH2;
- X2 and X3 are N or CH, with the proviso that X2 and X3 are not simultaneously N;
- X4 is N or CH;
- a and b are independently of one another 0, 1 or 2;
- and
- m, n, o and p are independently of one another 1, 2 or 3;
- and their pharmaceutically acceptable salts and prodrugs thereof.
12 more elements
-47. (canceled)
Dependencies are inferred from the claim text.